Business Description
Ypsomed Holding AG
ISIN : CH0019396990
Description
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.2 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.41 | |||||
| Debt-to-EBITDA | 1.58 | |||||
| Interest Coverage | 14.5 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.27 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8 | |||||
| 3-Year EBITDA Growth Rate | 32.9 | |||||
| 3-Year EPS without NRI Growth Rate | 191.8 | |||||
| 3-Year FCF Growth Rate | 10 | |||||
| 3-Year Book Growth Rate | 13.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 40.44 | |||||
| Future 3-5Y Total Revenue Growth Rate | 21.85 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.13 | |||||
| 9-Day RSI | 36.24 | |||||
| 14-Day RSI | 36.27 | |||||
| 6-1 Month Momentum % | 5.97 | |||||
| 12-1 Month Momentum % | 35.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.66 | |||||
| Quick Ratio | 0.51 | |||||
| Cash Ratio | 0.1 | |||||
| Days Inventory | 69.05 | |||||
| Days Sales Outstanding | 69.83 | |||||
| Days Payable | 24.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.56 | |||||
| Dividend Payout Ratio | 0.37 | |||||
| 3-Year Dividend Growth Rate | 114 | |||||
| Forward Dividend Yield % | 0.56 | |||||
| 5-Year Yield-on-Cost % | 0.95 | |||||
| 3-Year Average Share Buyback Ratio | -2.5 | |||||
| Shareholder Yield % | -1.5 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 35.44 | |||||
| Operating Margin % | 14.07 | |||||
| Net Margin % | 12.06 | |||||
| FCF Margin % | -14.04 | |||||
| ROE % | 12.31 | |||||
| ROA % | 6.93 | |||||
| ROIC % | 7.09 | |||||
| ROC (Joel Greenblatt) % | 18.45 | |||||
| ROCE % | 13.26 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 65.97 | |||||
| Forward PE Ratio | 44.09 | |||||
| PE Ratio without NRI | 65.97 | |||||
| Shiller PE Ratio | 112.18 | |||||
| Price-to-Owner-Earnings | 119.26 | |||||
| PEG Ratio | 5.54 | |||||
| PS Ratio | 7.94 | |||||
| PB Ratio | 7.88 | |||||
| Price-to-Tangible-Book | 15.4 | |||||
| Price-to-Operating-Cash-Flow | 31.32 | |||||
| EV-to-EBIT | 59.01 | |||||
| EV-to-Forward-EBIT | 31.62 | |||||
| EV-to-EBITDA | 31.28 | |||||
| EV-to-Forward-EBITDA | 17.67 | |||||
| EV-to-Revenue | 8.21 | |||||
| EV-to-Forward-Revenue | 6.53 | |||||
| EV-to-FCF | -56.93 | |||||
| Price-to-Projected-FCF | 68.52 | |||||
| Price-to-DCF (Earnings Based) | 4.06 | |||||
| Price-to-Median-PS-Value | 1.91 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.22 | |||||
| Price-to-Graham-Number | 6.7 | |||||
| Earnings Yield (Greenblatt) % | 1.7 | |||||
| FCF Yield % | -1.76 | |||||
| Forward Rate of Return (Yacktman) % | 10.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ypsomed Holding AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 617.072 | ||
| EPS (TTM) (CHF) | 5.45 | ||
| Beta | 0.35 | ||
| Volatility % | 28.88 | ||
| 14-Day RSI | 36.27 | ||
| 14-Day ATR (CHF) | 11.069561 | ||
| 20-Day SMA (CHF) | 376.8625 | ||
| 12-1 Month Momentum % | 35.26 | ||
| 52-Week Range (CHF) | 288.5 - 439 | ||
| Shares Outstanding (Mil) | 13.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ypsomed Holding AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ypsomed Holding AG Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ypsomed Holding AG Frequently Asked Questions
What is Ypsomed Holding AG(CHIX:YPSNz)'s stock price today?
The current price of CHIX:YPSNz is CHF357.00. The 52 week high of CHIX:YPSNz is CHF439.00 and 52 week low is CHF288.50.
When is next earnings date of Ypsomed Holding AG(CHIX:YPSNz)?
The next earnings date of Ypsomed Holding AG(CHIX:YPSNz) is .
Does Ypsomed Holding AG(CHIX:YPSNz) pay dividends? If so, how much?
The Dividend Yield %  of Ypsomed Holding AG(CHIX:YPSNz) is 0.56% (As of Today), Highest Dividend Payout Ratio of Ypsomed Holding AG(CHIX:YPSNz) was 0.86. The lowest was 0.16. And the median was 0.3. The  Forward Dividend Yield % of Ypsomed Holding AG(CHIX:YPSNz) is 0.56%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers